The electronic health record has long been the backbone of clinical evidence, but its limits are showing....
real-world evidence
The landscape of regulatory evidence is undergoing its most significant shift in decades. In 2026, real-world data...
Digital health registries promise real-world evidence at scale, yet a surprising number of submissions stall or receive...
Real-world evidence submissions increasingly depend on patient registries that span dozens of hospitals, specialty clinics, and academic...
The conversation around patient-generated wearable data in regulatory submissions has shifted from speculative to operational. Sponsors no...
Using registry data to produce real-world evidence (RWE) is widely recognized as a powerful complement to randomized...
For most digital therapeutics (DTx) companies, the phrase “DTx reimbursement: using RWE to satisfy CMS in 90...
As digital therapeutics (DTx) expand into chronic disease management, the pressure to generate compelling evidence for payer...
For digital therapeutic (DTx) startups, the question is no longer whether real-world evidence matters, but how to...